Case in Point, the Rubella vaccine

This is done with your tax dollars!

This cell line has been preserved for decades and is continually put through cellular division to create more substrate for continued vaccine development. Today, the WI-38 cell line is used in the development of vaccines targeting varicella (chickenpox) rubella (in the MMR vaccine), hepatitis A, shingles (Zoster) vaccine, and rabies vaccines

The MCR-5 cell line cells are used to make today’s diphtheria, tetanus, pertussis (DTP) vaccines, hepatitis A and B vaccines, polio and adenovirus vaccines. In 1985, US researchers developed cell line PER C6, which was taken from the retina of a carefully selected, aborted baby. It was used in the development of vaccines for Ebola and HIV.

Multiple aborted baby cell lines were procured for development of Rubella vaccine.

 

2 thoughts on “Case in Point, the Rubella vaccine

Comments are closed.